Evaxion Biotech A/S Quarterly Liabilities in USD from Q4 2019 to Q4 2024

Taxonomy & unit
ifrs-full: USD
Summary
Evaxion Biotech A/S quarterly Liabilities history and growth rate from Q4 2019 to Q4 2024.
  • Evaxion Biotech A/S Liabilities for the quarter ending December 31, 2024 was $14.1M, a 19.8% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $14.1M -$3.48M -19.8% Dec 31, 2024 20-F 2025-04-01
Q2 2024 $14M -$241K -1.7% Jun 30, 2024 6-K 2024-08-14
Q4 2023 $17.6M +$3.9M +28.4% Dec 31, 2023 20-F 2025-04-01
Q2 2023 $14.2M +$365K +2.64% Jun 30, 2023 6-K 2023-08-17
Q4 2022 $13.7M +$6M +77.6% Dec 31, 2022 20-F 2024-03-26
Q2 2022 $13.9M +$8.03M +138% Jun 30, 2022 6-K 2022-08-11
Q1 2022 $14.7M +$7.57M +106% Mar 31, 2022 6-K 2022-05-12
Q4 2021 $7.73M +$2.8M +56.8% Dec 31, 2021 20-F 2023-04-28
Q3 2021 $7.47M Sep 30, 2021 6-K 2021-11-10
Q2 2021 $5.83M Jun 30, 2021 6-K 2021-08-13
Q1 2021 $7.12M Mar 31, 2021 6-K 2021-05-14
Q4 2020 $4.93M +$3.21M +186% Dec 31, 2020 20-F 2022-03-31
Q4 2019 $1.72M Dec 31, 2019 20-F 2021-04-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.